GlassScriptPhysician profile
Carolyn Hesson
NPI 1710482419
$1,534.13
in general payments reported to CMS, 2019-2025
18 companies · $516 in 2025
The $516 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $295 · 2024: $723 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,423 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,422.64 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $571.84 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $245.50 | 2024 | Austedo Xr, Ajovy |
| Lilly USA, LLC | $87.36 | 2023-2025 | Jardiance, Mounjaro |
| Pfizer INC. | $78.16 | 2023-2024 | |
| Astellas Pharma US INC | $75.72 | 2025 | Veozah |
| Amgen INC. | $72.55 | 2024-2025 | Otezla, Repatha, Repatha |
| Novo Nordisk INC | $66.32 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $66.18 | 2024-2025 | Rexulti |
| Abbott Laboratories | $64.43 | 2023-2025 | Freestyle Libre 3 |
| Lundbeck LLC | $39.63 | 2024 | Rexulti, Vyepti |
| Dexcom, INC. | $37.09 | 2024 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $30.24 | 2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Axsome Therapeutics, INC. | $23.96 | 2025 | Symbravo |
| Boston Scientific Corporation | $19.25 | 2024 | Wavewriter Alpha Prime 16 |
| Azurity Pharmaceuticals, INC. | $14.76 | 2025 | Alvesco |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $14.07 | 2023 | Tirosint, Licart |
| Exact Sciences Corporation | $14.03 | 2024 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $13.04 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolyn Hesson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.